2 news items
BrainStorm Cell Therapeutics to Present New Biomarker Data Suggesting ALS Patients May Benefit From Longer-Term Treatment with NurOwn
BCLI
20 May 24
from the NurOwn Expanded Access Program (EAP) along with data from the Phase 3 trial.
BrainStorm Cell Therapeutics to Present New Biomarker Data Suggesting ALS Patients May Benefit From Longer-Term Treatment with NurOwn
BCLI
20 May 24
Expanded Access Program (EAP) along with data from the Phase 3 trial
- Prev
- 1
- Next